Looking to expand your partner network with leading companies like MSD? Consider joining Inpart's global network for free.
News and Trends 11 May 2021
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for blood cancer. This has given a major confidence boost to other European companies in the field as the deal mill picks up speed. Last month, ADC Therapeutics in Switzerland broke into the mainstream when its lead candidate Zynlonta received FDA […]